Jacobs Levy Equity Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-861,801	Closed	-$9.53M	–	1096
2023 Q2	$9.53M	Sell	861,801 -61,568	-7%	-$858K	0.05%	283
2023 Q1	$12.4M	Buy	923,369 +262	+0%	+$4.53K	0.08%	253
2022 Q4	$11.4M	Buy	923,107 +142,162	+18%	+$2.01M	0.08%	263
2022 Q3	$10.9M	Buy	780,945 +135,254	+21%	+$2.18M	0.09%	246
2022 Q2	$8.92M	Buy	645,691 +53,387	+9%	+$855K	0.07%	300
2022 Q1	$9.64M	Buy	592,304 +3,382	+0.6%	+$53K	0.06%	299
2021 Q4	$9.59M	Buy	588,922 +54,746	+10%	+$923K	0.06%	309
2021 Q3	$7.93M	Sell	534,176 -79,712	-13%	-$1.28M	0.05%	349
2021 Q2	$12.3M	Buy	613,888 +81,786	+15%	+$1.62M	0.08%	255
2021 Q1	$12.3M	Buy	532,102 +52,378	+11%	+$1.46M	0.09%	248
2020 Q4	$11.8M	Buy	479,724 +132,478	+38%	+$4.39M	0.1%	226
2020 Q3	$14.4M	Buy	347,246 +297,789	+602%	+$13.7M	0.15%	156
2020 Q2	$2.37M	Buy	49,457 +5,455	+12%	+$421K	0.03%	495
2020 Q1	$2.77M	Sell	44,002 -340	-0.8%	-$30.6K	0.04%	416
2019 Q4	$5.5M	Buy	44,342 +4,050	+10%	+$363K	0.05%	351
2019 Q3	$2.67M	Buy	+40,292	New	+$2.71M	0.03%	454
2016 Q3	–	Sell	-8,120	Closed	-$1.16M	–	1159
2016 Q2	$1.16M	Sell	8,120 -4,920	-38%	-$717K	0.02%	545
2016 Q1	$1.68M	Buy	+13,040	New	+$1.54M	0.04%	450